Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Byrd

Showing results (81-90 of 681) with videos related to

Pageof 69
Sort By:
Leukemia & Lymphoma|December 15, 2011
Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemiaJeffrey A Jones, Eric H Kraut, Deidre Deam, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
Molecular Complete Remission Following Ivosidenib in a Patient With an Acute Undifferentiated LeukemiaSandipkumar H Patel, Sumithira Vasu, Ling Guo, et al.
British Journal of Haematology|October 27, 2007
Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genesChristoph Plass, John C Byrd, Aparna Raval, et al.
Journal of Cutaneous Pathology|March 10, 2004
Atypical lymphocytic lobular panniculitisCynthia M Magro, A Neil Crowson, John C Byrd, et al.
Rapid Communications in Mass Spectrometry : RCM|March 9, 2006
Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification methodZhongfa Liu, Guido Marcucci, John C Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Entering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinicianJohn C Byrd, Jeffrey J Jones, Jennifer A Woyach, et al.
Annals of Internal Medicine|September 20, 2006
Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemiaTait D Shanafelt, John C Byrd, Timothy G Call, et al.
The EMBO Journal|July 14, 2007
Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphomaSharmistha Pal, Robert A Baiocchi, John C Byrd, et al.
Anticancer Research|September 16, 2016
Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLLIngo G H Schmidt-Wolf, Christoph Plass, John C Byrd, et al.
Cancer Research|January 21, 2006
CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemiaTe-Hui Liu, Aparna Raval, Shih-Shih Chen, et al.
Pageof 69

Showing results (81-90 of 681) with videos related to

Sort By:
Pageof 69
Leukemia & Lymphoma|December 15, 2011
Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemiaJeffrey A Jones, Eric H Kraut, Deidre Deam, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
Molecular Complete Remission Following Ivosidenib in a Patient With an Acute Undifferentiated LeukemiaSandipkumar H Patel, Sumithira Vasu, Ling Guo, et al.
British Journal of Haematology|October 27, 2007
Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genesChristoph Plass, John C Byrd, Aparna Raval, et al.
Journal of Cutaneous Pathology|March 10, 2004
Atypical lymphocytic lobular panniculitisCynthia M Magro, A Neil Crowson, John C Byrd, et al.
Rapid Communications in Mass Spectrometry : RCM|March 9, 2006
Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification methodZhongfa Liu, Guido Marcucci, John C Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Entering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinicianJohn C Byrd, Jeffrey J Jones, Jennifer A Woyach, et al.
Annals of Internal Medicine|September 20, 2006
Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemiaTait D Shanafelt, John C Byrd, Timothy G Call, et al.
The EMBO Journal|July 14, 2007
Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphomaSharmistha Pal, Robert A Baiocchi, John C Byrd, et al.
Anticancer Research|September 16, 2016
Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLLIngo G H Schmidt-Wolf, Christoph Plass, John C Byrd, et al.
Cancer Research|January 21, 2006
CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemiaTe-Hui Liu, Aparna Raval, Shih-Shih Chen, et al.
Pageof 69